Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CEL | P19835 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172849 | 0.91 | CEL (0.32) | CELHTR1AHTR7LMNA | |
| SCHEMBL20172839 | 0.90 | HTR2C (0.36) | CELHTR1AHTR7 | |
| SCHEMBL20650459 | 0.88 | CEL (0.32) | CELHTR1AHTR7LMNA | |
| SCHEMBL20172854 | 0.88 | CEL (0.36) | CELHTR1AHTR7 | |
| SCHEMBL20172805 | 0.84 | CEL (0.34) | CELHTR1AHTR7LMNA | |
| SCHEMBL21982426 | 0.84 | PTGS2 (0.33) | CELHTR1AHTR7 | |
| SCHEMBL20172810 | 0.83 | CEL (0.33) | CELHTR1AHTR7 | |
| SCHEMBL20172793 | 0.83 | CYP2C19 (0.35) | CELHTR1AHTR7LMNA | |
| SCHEMBL21020575 | 0.83 | KMT2A (0.34) | LMNA | |
| SCHEMBL20172850 | 0.83 | HTR2C (0.36) | CELHTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | CEL 3965/4885HTR1A 2933/4885HTR7 3018/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | CEL 3965/4885HTR1A 2933/4885HTR7 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.